Novacyt

Novacyt is a publicly traded molecular diagnostics company with a mission to be a trusted provider enabled by technical expertise, innovation, and global partnerships. The company has achieved significant scale and diversification through strategic acquisitions, including Primerdesign, Yourgene Health, and Southern Cross Diagnostics, creating an integrated business model spanning R&D, manufacturing, and global distribution. Its strategy focuses on leveraging its multi-brand portfolio to deliver end-to-end solutions in high-growth areas like reproductive health, precision medicine, and infectious disease.

Integrated suite of molecular technologies including qPCR assays (Primerdesign), NGS workflows & automated DNA size selection (Yourgene Health's Ranger® Technology), and benchtop PCR instrumentation.

Novacyt competes with large diversified players (Qiagen, Thermo Fisher) in qPCR/infectious disease and specialists (Illumina, Natera) in NIPT. Its strategy relies on open-platform flexibility, vertical integration, and a multi-brand approach to differentiate itself in a crowded market.